Fatty liver disease, now termed MASLD, is increasingly prevalent, particularly among those with weight issues, diabetes, or ...

Fat accumulation in the liver, common in both non-drinkers (NAFLD, now MASLD) and those who consume alcohol (AFLD), may ...

UAB researchers have reversed metabolic dysfunction-associated steatohepatitis (MASH) in mouse models. MASH is a severe liver disease associated with obesity and type 2 diabetes that affects more ...

Landmark trials have shown that GLP-1 receptor agonists, originally developed for diabetes and weight loss, also provide ...

Metabolic dysfunction-associated steatohepatitis (MASH) represents a serious form of fatty liver disease that can lead to permanent damage while producing few noticeable symptoms.

The Food and Drug Administration is expected to approve the first medicine developed specifically to treat the serious liver disease known as MASH as soon as this week. The pill, called resmetirom ...

In his 40s, Álvarez was diagnosed with fatty liver disease. Genetics can play a role, and he later learned that his mother had the same condition. "Navigating this journey has deepened my ...

Dapagliflozin helped people reduce fat levels in their liver and avoid liver scarring that comes with the condition, which doctors call metabolic dysfunction-associated steatohepatitis, or MASH ...

This new therapeutic for advanced-stage liver disease is significant because, until now, ... Of that population, 20% have the more advanced disease form, MASH.

In a placebo-controlled, 24-week Phase 2 test that enrolled 84 MASH patients in stages 2 or 3 of the disease (stage 4 is liver cirrhosis), Boston Pharma reported results showing statistically ...